American producer of drugs and personal care products, Johnson & Johnson had a slight growth in earnings in the past quarter.

This positive outcome is due to lower costs, according to the notice of the company. The net profit is 3.35 billion dollars or 1.20 dollars per share, which represents growth by 1.1% annually.
On the other hand, revenues from sales were reduced by 5.3% to 15.08 billion dollars.